Adiposidade central e adiponectina em pacientes em diálise peritoneal: uma análise prospectiva

!

"

#

$ !

! %

&"

#

$ !

!

'( ) *

! "#$%

& ' ( & &) )*!# ) & ' *) ! * )+ ' )*!)( )+ & $ ()

')# ! *) + *$ () '# (') ! ,

)() - ! # & . / !

! , - &. / !

0! 1 ! 2! 3 ! 4! ' !

'

(

'

7

" :

;

0

,

# & (

( ( *

)(!$ * !)+' )+ 1 ) ) ( & # +2

+ ( *

*!)*( & &)

+ 1 )

*!) )+3

# (( )4 (!)+ + +)*! ( *)(1 ) 5,) (2

( ( *)4'

$,) (

) ')((

( *

+' #$,) (36

)&

!7#

>

??

'

@

8 +

*&#

!!!

'

8

%#)&

!!!

=3

7

>

7

,

3

A

>

7

"# &) +)*!

(')

C

>

@ 7

# % 3

# 3

*

'' #

@ ,

$

$

@

>

@

> $

$

@

D

7

@

A

@

@

!

>

"# &) +)*! (

9 ')((

( + ! )(')

(2

C

> 7

,

&

# % 3

# 3

#

: ; < + + #

@

@

@

>

$

> !

D

$

$

> ??? ',

@

@

> ???

C

>

,

@

,

$

@

# + = )& * = #

')(@

@

E

! F

A

7

,

> @

A

>

!!!!> B

??? F

3

>

B

,

$

! /

E

A

??? '

!

$ E

7

!!!!

C

> 7

,

,

#

(( * &)

>

)

> 2

> @

E

7

??? "

,

7

> ,

$

! F

7

!!!! A

!!!!7

D

?? F

A

,

!!!!

',

= ?# )

) )#* *&

@

>

>

&# *

@

-

@

7

E

> !

>

7

* )

@ 7

<

,

,

>

?

C

>

$

!!!!!

8

8

??9@

!

@

@

(!),

@

)&#

*

@

B

G

7

C

,

( * &

$ ()

)!)(2

7

>

A,

>

H

! ',

@

> @

E

! F

"# &) +)*! (

C

$

3

*& A

(B &

+ (@

,

3

@

B

7

$

!

C

7

$ ()

)# ! *)

@

$

5 , 2

+

2

C? # 2

( &

! #)(

#

)

#

&

) D

* ) A

2

E

>

7

!

'

&

! #)(

>

)

#

"E*

@

,

3

7

>

@

@

D

7

! '

>

?

C 7

- ,

&

? *

-

3

! ',

@

!

* +)*!)2 + ! ?# " & D( ')(( ( 1 ) * !) 2 + ( 1 ) &) % #+ )(')

( '

)*!)(2

',

7

$ E

7

,

!

@

7

!

',

@

@

A

3

)( + 3333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333

I0

3

), (

&

!)# ! # 33333333333333333333333333333333333333333333333333333333333333333333333333333333

I4

G3

)%)#E*

(

?

"#$%

( 33333333333333333333333333333333333333333333333333333333333333333333333

46

H3

?I)! , ( 3333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333

65

J3

(! &

( ?+)! & D ' ?

A

$

$ :

$

)

$

(

(

#

&

(

333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333333

66

J3 3

*% #+ A

&) ' ?

A

& )(! & 333333333333333333333333333333333333333333333

H2

K3

(! &

( ?+)! & D ' ?

A

J

$

$

(

# 02&

> $

:&

(

LL3

K3 3

*% #+ A

&) ( ?+ ((

LLLLLLLLL333LLLLLL

H4

0IK

M3

*( &)# AN)( % * ( 3333333333333333333333333333333333333333333333333333333333333333333333333333333

0IL

O3

'# , A

& )(! & ')

+ !E &) P!

)+ )(1 ( &

1

!"

#

$

%

&

'

(

#

#

%

) $

%

"

*

%

#

$

$

+

#

,-'

,

.

%

$

%

$

,

#

&

%

$

% "

!

/

%

0

%

(

%

$

$

/

!

0

(

#

#

%

)

#

1

%

$

%

$

%

%

#

,-

(

.

$

$

$

2

' %

'

$

!

"

"

'

$

$

1

%

#

$

3

,

#

$

#

$

,

*

!

!

/

4

$ & 5

$

$

#

6

789

#

:;< (

:4=79

>:<

$

?@

4A B=> C D E

_$

"F

!

$

>

!

'

,

#

$

' ;

2

G 8 B7H +I8 887

*

#

?@

β

G 8 >8H +I8 887H

_{G 8 99}

_/

_{8 :C}

J

#

$

2

8 C8 0

#

"

G 8 ACH +I8 887 2

J

8 AB

/

2

,

!

#

$

8 9; 0

#

%

*

?@

$

,

2

$

$

#

?

!

!

#

#

6

77:

#

K:9< (

>7<

$

:4 B

±

7; 7

?@

4: 8=A > D E

_#

_{7> :">>}

L

$

>

%

)M?N

!

'

,

#

$

' ;

74

"

G "8 ABH +I8 887

*

$

%

%

β

G "8 :4H

C:<

? "8 9>

8 >7H +I8 887 0

#

'

*

$

%

%

+

7

(

%

8 >C

EM

+ I8 887

!

!

3

N

0J6E 2O? P

E

%

&

%

;8

E

E7 9>

>

₍

_%

_$

4

_Q#

,-4

!"

#

$

%

&

'

%

(

#

,

!

#

,

!

'

$

#

%

#

(

#

2 .

RN

N P R

N

NS

,

)

R

488B C><

(

#

9<

#

₀

_T

_.

N

T

0

488C

,

BC ;<

(

#

78 A<

#

₎

4

%

,

1 (

#

#

#

5

%

#

%

#

%

$

&

#

*

%

#

%

%

%

'&

&

&

#

,

%

#

6

7

#

%

$

#

%

!

&

%

#

%

%

#

7 :< A 4:<

$

+

!

#

$

!

U

),

$

+

+)U P

!"

# $

,

"

"$ &

$ &

_%

_#

!

.

E

%

%

5

+ #

#

!

%

#

$

+

#

!

+

+

( $

! %

A

:

#

%

#

,

%

$

4 8

4 :

A

B (

0

#

(#

%

%

%

#

+

$

+

! %

> 78

#

%

#

,

+

%

$

;

%

%

!

! %

,

,

%

+

& $

( #

%

6

T

!

::<

#

$

1

#

%

.

,

"

%

'

#

'

2

#

%

"

*# ,

%

&

,

$

&

%

%

,

$

%

%

"

$

(

₊

_$

_%

_*

_%

,-

$

$

$

. $

,

$

1

#

2

(

.

%

'

_,

₍

"

&

$

_@

7;

_78A;B

_#

,

>7<

$

V

@

7

(

$$

_,

_7;;4

$

RN

N P R

N

NS

2

$

,

7;;4

#

44 <

?@

≥

>8 D E

_$

_T

_W+

_"

T !

+

S

@

N

S

_,

_>44;

_#

(

2

,

4B<

"

?@

$

0

$

>B<

_!

A:

#

$

>><

$

7: ;<

,

%

#

!

_$

_F

B 74

_,

_,

#

)

A:

#

$

:><

7; > = ; C

7C A = 9 BD

74

(

₂

_.

%

$

6

X

7C

+

$

"

,

7:

(

!

@

;8

#

$

$

!

$

/

8

) $

(

*

$

1

(

%

$

77

_$

_%

1

$

44

₎

_;8<

_%

_#

$

_%

₊

₇₈₈

488

%

$

4A (

,

A88

;88

D

E

_Q#

₊

_$

_%

₇₈₈

$

%

%

48

>8<

#

₀

!

%

!

%

$

%

(

_N

_"

_,

%

*

%

$

,

,

(

%

,

$

% 1,

,

!

2

(

.

%

'

#

,

$

&

$

U

,

.

$

$

1

#

.

9

,

,

$

#

!

$

5

$

/

$

/

.

Q#

%

$

6

4

Y $

!

/

%

%

,

%

$

%

!

$

$

/

)

$

(

!

%

%

!

$

#

10

$

"F

)F

%

$

,

,

!

$

0

$

%

$ !

! %

&

.

$

!%

E,

/

$

,

$ &

#

&

%

%

!

,

(#

%

#

)

!

,

*

$

#

U $

7

#

%

$

"

#

$

!

!

'

B8

!

%

$

_%

_!

,

%

#

&

%

$

$

/

_{2 ,}

"F

2

"F

%

%

2

'

11

>:

_%

_.

>;

+

%

$

#

J S J N Q 7CC>>:

0 5 % %

$

'

&

$

!

&

#

.

%& ! ' ( ) # * # " # $ U Z E $

$ / 4 >

↑↑ ↑↑ ↓↓ + # # ' Z E $

$ / 4 >

↑↑ ↑ ↓↓

,

-. @ Y ↑ 0 ↓

* - " U

+ $

↓ ↓ ↑

12

$

,

$

$ ,

$

>> >9

+ #

#

/

,

$

%

#

,-

2

%

$

%

&

! %

/

$

"

,

&

,

>B

/

!

_&

_$

,

$

,

&

1

%

,

%

.

&

78

!

,

/

$

! ,

,

! %

,

,

13

,

/-.

$

"F

)F

.

'

%

6

>

U $ "F

)F

#

%

1

%

$

#

₎

_$

_%

_"F

%

$

$

2

$#

)F

! %

"F

,

&

"F

$ &

,

14

0 % , # $ "F

)

#

#

%

)F

_{N *}

7AB

#

%

!

(

5 G 8 9A

(

5 G 8 9:H +

I 8 87 J

$

(

(

%

,

(

,

?@

,

!

0

)F

%

₀

%

0

N

(

744

%

$

,

%

!

1

%

,

7 4 > ) # # T & )

7 "Y

4 "@

> "2

7 4 > ) # # T & )

7 "Y

4 "@

15

AC

₂

_,

)F

'

1

)F

#

&

%

% "

%

,

(

,

&

%

%

1

$ &

&

%

1

%

,

,

,

,

$ !

! %

0 *

-

"

"

,

$

%

R

&%

!

2

%

#

,

( *

%

3#

%

$

"

!

_[#

,

" $

"

$

%

$'

+

%

!

%

!

"

'

! %

#

16

,

_,

_!

_"

%

$

#

,

%

%

,

$

#

1 ,

@

%

#

&

%

$ &

%

'

0

,

$

%

7C98

(\

$

!%

& 0

7CB8

,

!%

E,

%

,

!%

E &

%

$

'

'

_#

&

!%

E

_!%

_/

$

E

&

₊

_/

$

(

$

E

%

U $

4

%

$

@

%

$

!

!

*

#

'

U

,

!

%

% $ '

17

?

$

@ N Q 7CCB;C

2 #

" 3 #

#

$ &

#

&

%

$

6

:

,-

#

. $

$'

3#

,

$

4 # ) # # # & #

$ # 5# /

" T %

$'

" N

$ # 5' " T $

" N

+

" T %

" 2$ % , $

$ # 5

" T

" $

$ %

6 # # #

" *

" ? % &

$ +

5# # " 3 # # /

" T $

" N

2 # " 3 # #

" T % $

18

%

$

$

&

₎

_%

_*

_7B

_BB

Q

_,

_$

$

$

/

]G 8 :4

(

]G 8 AC (

H + I8 87

]G 8 9;

(

]G 8 :: (

H + I8 87

(

$

3

_7C>A

::

9:

2

%

$

$

/

_{G8 :9}

₍

_{G8 :: (}

_H

+I8 87

_{G8 9C}

₍

_{G8 ;: (}

_{H +I8 87}

$

$

%

)F

_{G8 B4}

₍

_{G8 B> (}

_H

+I8 87

₍

_$

_$

_{"6 (}

_,

(

%

G 8 ::H + I8 87 0

!

^

_,

_$

,

(

'

&

%

G8 B4H +I8 87

,

$

%

G8 >8H +G8 8:

1 ? % %

19

0

%

)

!

,

744

% "

$

$

G8 9: (

G8 B7

(

H

I8 87

$

/

G8 B7 (

G8 9B

(

H

I8 87

₀

(

#

#

%

)

#

1

%

$

%

$

%

%

#

,-

(

.

$

$

$

0

_,

'

%

%

#

%

$

#

%

$

( $

$

3

J

S

9B

$

$

7>

,

(

%

$

/

/

J

_,

_>:

_$

_{E $}

;

)

% "

>4

(

"

M

&

_,

!

(

0

9

20

'

*

>A

#

#

%

,

!

$

!

)F

0

( $

$

%

!

%

$

3

_,

%

%

!

) $

(

β

G 7 8CH ? G 7 8;PB >;H +G 8 8>B

$

$ &

/

#

/

J

8 4;

$

$

1 (

#

#

%

&

,

#

$

$

N

$

)F

!

/

#

.

21

>: ;: ;C 9C

_!

_$

%

0

)

7CA9

Q

3

,

%

%

$

#

$

_{$ "}

_,

_%

'

$

' %

.

,

(#

%

$

'

%

$

_{) $}

_%

(

$

,

.

$

$

/

$'

(

/

$'

₁

/

1

₍

_%

$

$

/

( '

$

,

.

*

( '

$

"

'

&

.

'

!

BB

_U

_#

_%

% 1,

22

%

'"

'

% 1

$

/

(#

&

%

$

%

&

_ " ++

_

%

$

/

_{( '}

_$

_"

&

2

*

#

&

% "

%

$

%

+

,

.

&

%

1

#

&

% "

U

,

%

$

,

. $

)

%

$

N

T

(

_,

_,

%

$

,

$

/

%

1

,

1

,

$

R

&

%

,

.

&

$

4

_,

$

C; C9

0

$

&

$

$

23

#

!

,

1

#

,

&

)

`

(

_,

%

'

(

#

0

#

M

%

!

%

,

&

$

$

%

$

$

$

(

#

Y (

_,

,

$

/

1

%

"

(

#

2

,

$

/

$

1

,

$

"

0

% "

!

,

,

$

/

#

!

[ M"

(

1

"

₎

₍

_Y

₍

,

$

%

$

/

1

,

$

/

$

&

24

%

$'

$

$

#

,

B8 )

,

$

$

78A

₎

_$

%

%

#

%

%

[ M"

0

!

$'

$

@

B89

%

$

,

( '

,

$

%

N

(

_,

+

$

(

#

,

0

#

25

1

#

#

(

' %

'

&

$

,

!

!

"; ?M";

"7 ?M"7

"

α

U06"

α

&

%

%

'"

'

%

#

$

%

%

$ (

,

%

%

.

(

'

%

'

,

$

,

%

#

'&

#

1

1

$

4

_N

%

"

"

'

1

,

#

!

7CC8

26

,

&

a

(

$

8 87<

#

N

"

>

5 "

0"

%

,-

#

H "

(

#

(

(

#

3?? F

7, H "

$

%

"

,

$ &

( &/

&

%

%

5

7

4 2

7

&

$

.

,

,

,

4

&

)

1

'

&

%

1

,

_%

_#

"

!

$

1

6

,

%

*

$

4 ,

1,

!

?@

747

_!%

_,

₂

_,

_%

#

$

%

%

R

$ %

27

,

$

'

74B"7>8

_%

_,-

7>7 7>4 7>>

_$

_#

₍

R

,

%

47<

?@

(

A;<

7>A

)

"

$

%

$

$

%

'

%

'

&

%

%

&

%

U06"

α

!

%

₀

%

#

!

#

(

₎

_,

_%

,

$

#

$'

$

(

%

&

%

(

$

$'

+

&

_,

_(#

%

$

,

28

7 ,

#

2

2

,

(

#

#

#

&

!

,

#

₎

_%

(

&

. $

$

%

%

6

7

2

' %

$

%

%

%

#

₍

_%

7A>

_$

_%

_&

_%

%

#

0

$

29

↑ ↑ ↑

↑ ↑↑↑↑ ↑↑↑↑2 # ! # #

↑ #

↑) &

@ %

↓ ↓↓

↓ / 3 #

# ↓ ↓ ↓ ↓ ↓↓↓ ↓↓↓↓↓ ! # 6 % !

! 2 8 #

7 N $ %

! D 7A;

%

R

&

%

>8D

#

,

%

#

2

#

%

*

%

! ,

&

%

'

"

!

_Q#

_{# $}

_$

_,

_(#

&

&

%

#

"

₎

_&

30

U06"

α

?M";

$

&

%

$

%

'

₀

_%

(

#

_%

_%

_#

"

_?M";

₂

#

,

$

$

%

&

%

₆

₍

7:C

_'

_,

_&

_%

$

%

β

"

%

&

,

%

#

%

#

)

%

&

%

$

&

(

%

R

,

%

#

$

%

'

4C"b

D

)

,

#

*

%

%

,

&

%

"

!

'

,

#

" #9

# & #

R

(

$

!

W

7>C

_{4884 2}

₍

₄₄₉

₍

_#

31

,

,

7>C

_$

7;8

_?

_S

₍

_#

₀

%

T D

₄₄₉

,

( '

:8<

%

#

% 1,

+

?\ (

_,

7

µ

E

%

#

(

%

7A<

0

#

$

`

_:C

_#

>C

$

,

%

#

!

(

,

1,

!

_7BA

#

,

%

(

$

) $

(

,

!

(

(#

$

%

(

%

@

B48

$

,

7

µ

E

%

#

(

><

;<

)

32

#

%

)

74AC

(

#

(

_,

_%

_#

:

Q#

#

AA

!

_%

_$

_%

_%

_#

)

,

$

,

%

%

$ "

%

"

,

#

%

$

%

7A: 7;C 798

_@

_.

_%

_$

#

,

%

$

N%

,

%

$

)

(

#

2

D

_,

33

!

#

G "8 A4

G "8 ACH +I 8 887

0

#

@

%

AC

(

#

!

%

797

₂

_$

_,

797

₀

_%

%

N

D

_$

_%

$

$

)F

G "8 4CH +I8 87

$

$

!

)F

0

%

#

%

$

,

$'

%

2

%

%

b

_#

$

%

G

"8 >8H +I 8 8>B

0

(

#

U D

_$

%

$

&

34

W

(

#

)

:>9

%

G "8 4; +I 8 887

₎

$

,

%

(

#

0

Q#

79A

(#

!

,

$

%

35

" 3 #

:

" #

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation,

classification, and stratification. Am J Kidney Dis 2002;39:S1-266.

2. Censo de Diálise. 2009. (Accessado em http://www.sbn.org.br/index.php.)

3. Cendoroglo M, Sanderber C, Suassuma P. Insuficiência renal crônica: etiologia,

diagnóstico e tratamento. In: Sarvier, ed. Nefrologia, urologia, clínica. São Paulo; 1998:29-33.

4. USRDS Annual Data Report., 2010. (Accessado em http://www.usrds.org/atlas.htm.)

5. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients.

Blood Purif 1989;7:95-108.

6. Flanigan MJ, Rocco MV, Prowant B, Frederick PR, Frankenfield DL. Clinical

performance measures: the changing status of peritoneal dialysis. Kidney Int

2001;60:2377-84.

7. Ikizler TA. Nutrition and Peritoneal Dialysis. In: Mitch WE, Klahr S, eds. Handbook

of Nutrition and the Kidney. Philadelphia: Lippincott Williams & Wilkins, 2005: 228-244

8. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in

serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease

in lean body mass. J Am Soc Nephrol 2000;11:1303-9.

9. Johansson AC, Samuelsson O, Haraldsson B, Bosaeus I, Attman PO. Body

composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant

1998;13:1511-7.

10. Jager KJ, Merkus MP, Huisman RM, et al. Nutritional status over time in

36

11. Soreide R, Dracup B, Svarstad E, Iversen BM. Increased total body fat during PD

treatment. Adv Perit Dial 1992;8:173-6.

12. Heimburger O, Lonnqvist F, Danielsson A, Nordenstrom J, Stenvinkel P. Serum

immunoreactive leptin concentration and its relation to the body fat content in chronic renal

failure. J Am Soc Nephrol 1997;8:1423-30.

13. Jolly S, Chatatalsingh C, Bargman J, Vas S, Chu M, Oreopoulos DG. Excessive

weight gain during peritoneal dialysis. Int J Artif Organs 2001;24:197-202.

14. Nolph KD, Sorkin M, Rubin J, et al. Continuous ambulatory peritoneal dialysis:

three-year experience at one center. Ann Intern Med 1980;92:609-13.

15. Kurtz SB, Wong VH, Anderson CF, et al. Continuous ambulatory peritoneal dialysis.

Three years' experience at the Mayo Clinic. Mayo Clin Proc 1983;58:633-9.

16. McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for

peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit

Dial Int 2004;24:340-6.

17. Abbott KC, Glanton CW, Trespalacios FC, et al. Body mass index, dialysis modality,

and survival: analysis of the United States Renal Data System Dialysis Morbidity and

Mortality Wave II Study. Kidney Int 2004;65:597-605.

18. Fernandes N, Bastos MG, Cassi HV, et al. The Brazilian Peritoneal Dialysis

Multicenter Study (BRAZPD) : characterization of the cohort. Kidney Int Suppl

2008:S145-51.

19. Sanches FM, Avesani CM, Kamimura MA, et al. Waist circumference and visceral fat

in CKD: a cross-sectional study. Am J Kidney Dis 2008;52:66-73.

20. Fernstrom A, Hylander B, Moritz A, Jacobsson H, Rossner S. Increase of

intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int

37

21. Choi SJ, Kim NR, Hong SA, et al. Changes in Body Fat Mass in Patients after Starting

Peritoneal Dialysis. Perit Dial Int 2010;[Epub ahead of print].

22. Lindholm B, Bergstrom J. Nutritional aspects on peritoneal dialysis. Kidney Int Suppl

1992;38:S165-71.

23. Gahl GM, Hain H. Nutrition and metabolism in continuous ambulatory peritoneal

dialysis. Contrib Nephrol 1990;84:36-44.

24. Vychytil A, Horl WH. Nutritional and peritoneal dialysis. In: Wilkins LW, ed.

Handbook of nutrition and the kidney. Philadelphia; 2002:253-44.

25. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of

solute and fluid transport during peritoneal dialysis. Kidney Int 1992;41:1320-32.

26. De Santo NG, Capodicasa G, Senatore R, et al. Glucose utilization from dialysate in

patients on continuous ambulatory peritoneal dialysis (CAPD). Int J Artif Organs

1979;2:119-24.

27. Uribarri J, Leibowitz J, Dimaano F. Caloric intake in a group of peritoneal dialysis

patients. Am J Kidney Dis 1998;32:1019-22.

28. Fernstrom A, Hylander B, Rossner S. Energy intake in patients on continuous

ambulatory peritoneal dialysis and haemodialysis. J Intern Med 1996;240:211-8.

29. Grodstein GP, Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW. Glucose

absorption during continuous ambulatory peritoneal dialysis. Kidney Int 1981;19:564-7.

30. Shen W, Punyanitya M, Wang Z, et al. Visceral adipose tissue: relations between

single-slice areas and total volume. Am J Clin Nutr 2004;80:271-8.

31. Thaete FL, Colberg SR, Burke T, Kelley DE. Reproducibility of computed

tomography measurement of visceral adipose tissue area. Int J Obes Relat Metab Disord

38

32. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring

adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic

resonance. Am J Clin Nutr 1990;51:953-7.

33. Tokunaga K, Matsuzawa Y, Ishikawa K, Tarui S. A novel technique for the

determination of body fat by computed tomography. Int J Obes 1983;7:437-45.

34. Seidell JC, Oosterlee A, Thijssen MA, et al. Assessment of intra-abdominal and

subcutaneous abdominal fat: relation between anthropometry and computed tomography. Am

J Clin Nutr 1987;45:7-13.

35. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a

practical guide. Int J Obes Relat Metab Disord 1993;17:187-96.

36. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of

abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-7.

37. Marin P, Andersson B, Ottosson M, et al. The morphology and metabolism of

intraabdominal adipose tissue in men. Metabolism 1992;41:1242-8.

38. Dooms GC, Hricak H, Margulis AR, de Geer G. MR imaging of fat. Radiology

1986;158:51-4.

39. Sobol W, Rossner S, Hinson B, et al. Evaluation of a new magnetic resonance imaging

method for quantitating adipose tissue areas. Int J Obes 1991;15:589-99.

40. Abate N, Burns D, Peshock RM, Garg A, Grundy SM. Estimation of adipose tissue

mass by magnetic resonance imaging: validation against dissection in human cadavers. J

Lipid Res 1994;35:1490-6.

41. Mazess RB, Peppler WW, Harrison JE, McNeill KG. Total body bone mineral and

lean body mass by dual-photon absorptiometry. III. Comparison with trunk calcium by

39

42. Gotfredsen A, Jensen J, Borg J, Christiansen C. Measurement of lean body mass and

total body fat using dual photon absorptiometry. Metabolism 1986;35:88-93.

43. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for

total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr

1990;51:1106-12.

44. Stenver DI, Gotfredsen A, Hilsted J, Nielsen B. Body composition in hemodialysis

patients measured by dual-energy X-ray absorptiometry. Am J Nephrol 1995;15:105-10.

45. Snijder MB, Visser M, Dekker JM, et al. The prediction of visceral fat by dual-energy

X-ray absorptiometry in the elderly: a comparison with computed tomography and

anthropometry. Int J Obes Relat Metab Disord 2002;26:984-93.

46. Kamel EG, McNeill G, Van Wijk MC. Usefulness of anthropometry and DXA in

predicting intra-abdominal fat in obese men and women. Obes Res 2000;8:36-42.

47. Hill AM, LaForgia J, Coates AM, Buckley JD, Howe PR. Estimating abdominal

adipose tissue with DXA and anthropometry. Obesity (Silver Spring) 2007;15:504-10.

48. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National

Kidney Foundation. Am J Kidney Dis 2000;35:S1-140.

49. Leister-Rocha M, Kamimura MA, Cuppari L. Is truncal fat a reliable marker of

visceral adipose tissue in chronic kidney disease patients? . In: XV International Congress on

Nutrition and Metabolism in Renal Disease. Lausanne, Swtizerland: (Abstract); 2010.

50. Axelsson J, Rashid Qureshi A, Suliman ME, et al. Truncal fat mass as a contributor to

inflammation in end-stage renal disease. Am J Clin Nutr 2004;80:1222-9.

51. Lee P, O'Neal D, Murphy B, Best J. The role of abdominal adiposity and insulin

40

52. Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by

ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the

abdomen. Am J Med 1993;95:309-14.

53. Ribeiro-Filho FF, Faria AN, Azjen S, Zanella MT, Ferreira SR. Methods of estimation

of visceral fat: advantages of ultrasonography. Obes Res 2003;11:1488-94.

54. Armellini F, Zamboni M, Robbi R, et al. Total and intra-abdominal fat measurements

by ultrasound and computerized tomography. Int J Obes Relat Metab Disord 1993;17:209-14.

55. Gong W, Ren H, Tong H, et al. A comparison of ultrasound and magnetic resonance

imaging to assess visceral fat in the metabolic syndrome. Asia Pac J Clin Nutr 2007;16 Suppl

1:339-45.

56. Merino-Ibarra E, Artieda M, Cenarro A, et al. Ultrasonography for the evaluation of

visceral fat and the metabolic syndrome. Metabolism 2005;54:1230-5.

57. Guldiken S, Tuncbilek N, Okten OO, Arikan E, Tugrul A. Visceral fat thickness

determined using ultrasonography is associated with anthropometric and clinical parameters

of metabolic syndrome. Int J Clin Pract 2006;60:1576-81.

58. Bellisari A, Roche AF, Siervogel RM. Reliability of B-mode ultrasonic measurements

of subcutaneous adipose tissue and intra-abdominal depth: comparisons with skinfold

thicknesses. Int J Obes Relat Metab Disord 1993;17:475-80.

59. Ashwell M, Chinn S, Stalley S, Garrow JS. Female fat distribution--a photographic

and cellularity study. Int J Obes 1978;2:289-302.

60. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in

men and women. Importance of regional adipose tissue distribution. J Clin Invest

1983;72:1150-62.

61. Hartz AJ, Rupley DC, Jr., Kalkhoff RD, Rimm AA. Relationship of obesity to

41

62. Higgins M, Kannel W, Garrison R, Pinsky J, Stokes J, 3rd. Hazards of obesity--the

Framingham experience. Acta Med Scand Suppl 1988;723:23-36.

63. Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol

1991;44:955-6.

64. Kahn HS. Choosing an index for abdominal obesity: an opportunity for epidemiologic

clarification. J Clin Epidemiol 1993;46:491-4.

65. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal

diameter: best simple anthropometric indexes of abdominal visceral adipose tissue

accumulation and related cardiovascular risk in men and women. Am J Cardiol

1994;73:460-8.

66. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Visser M. Abdominal diameters

as indicators of visceral fat: comparison between magnetic resonance imaging and

anthropometry. Br J Nutr 1993;70:47-58.

67. Sampaio LR, Simoes EJ, Assis AM, Ramos LR. Validity and reliability of the sagittal

abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metabol

2007;51:980-6.

68. Bouchard C, Bray GA, Hubbard VS. Basic and clinical aspects of regional fat

distribution. Am J Clin Nutr 1990;52:946-50.

69. Molarius A, Seidell JC. Selection of anthropometric indicators for classification of

abdominal fatness--a critical review. Int J Obes Relat Metab Disord 1998;22:719-27.

70. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist

circumference independently contribute to the prediction of nonabdominal, abdominal

42

71. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM. Influence of

body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab

2006;91:4459-66.

72. Despres JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of

deep abdominal adipose-tissue accumulation from simple anthropometric measurements in

men. Am J Clin Nutr 1991;54:471-7.

73. Nurmi J, Korkeila M, Honkanen E, Lindgren L, Castren M. Effect of peritoneal

dialysis on abdominal circumference. Perit Dial Int;30:215-7.

74. van der Kooy K, Leenen R, Seidell JC, Deurenberg P, Droop A, Bakker CJ. Waist-hip

ratio is a poor predictor of changes in visceral fat. Am J Clin Nutr 1993;57:327-33.

75. Kamel EG, McNeill G, Van Wijk MC. Change in intra-abdominal adipose tissue

volume during weight loss in obese men and women: correlation between magnetic resonance

imaging and anthropometric measurements. Int J Obes Relat Metab Disord 2000;24:607-13.

76. Lemieux S, Prud'homme D, Tremblay A, Bouchard C, Despres JP. Anthropometric

correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes Relat Metab

Disord 1996;20:618-24.

77. Aslam M, Eckhauser AW, Dorminy CA, Dossett CM, Choi L, Buchowski MS.

Assessing Body Fat Changes during Moderate Weight Loss with Anthropometry and

Bioelectrical Impedance. Obes Res Clin Pract 2009;3:209.

78. Velludo CM, Kamimura MA, Sanches FM, et al. Prospective evaluation of waist

circumference and visceral adipose tissue in patients with chronic kidney disease. Am J

Nephrol 2010;31:104-9.

79. Wang J, Thornton JC, Bari S, et al. Comparisons of waist circumferences measured at

43

80. Bonora E, Micciolo R, Ghiatas AA, et al. Is it possible to derive a reliable estimate of

human visceral and subcutaneous abdominal adipose tissue from simple anthropometric

measurements? Metabolism 1995;44:1617-25.

81. Vague J. La differentiation sexuelle, facteur determinante des formes de l’obésité.

Presse Med 1947;55:339-40.

82. Hermsdorff HH, Monteiro JB. [Visceral, subcutaneous or intramuscular fat: where is

the problem?]. Arq Bras Endocrinol Metabol 2004;48:803-11.

83. Bergman RN, Kim SP, Catalano KJ, et al. Why visceral fat is bad: mechanisms of the

metabolic syndrome. Obesity (Silver Spring) 2006;14 Suppl 1:16S-9S.

84. Lee CC, Glickman SG, Dengel DR, Brown MD, Supiano MA. Abdominal adiposity

assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin

sensitivity in older adults. J Gerontol A Biol Sci Med Sci 2005;60:872-7.

85. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional

adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly

men and women. Diabetes Care 2003;26:372-9.

86. Hermans MP, Pepersack TM, Godeaux LH, Beyer I, Turc AP. Prevalence and

determinants of impaired glucose metabolism in frail elderly patients: the Belgian Elderly

Diabetes Survey (BEDS). J Gerontol A Biol Sci Med Sci 2005;60:241-7.

87. Carneiro G, Faria AN, Ribeiro Filho FF, et al. [Influence of body fat distribution on

the prevalence of arterial hypertension and other cardiovascular risk factors in obese patients].

Rev Assoc Med Bras 2003;49:306-11.

88. Obesity: preventing and managing the global epidemic. Report of a WHO consultation

on obesity. In: World Health Organization. Geneva, Switzerland; 1998.

89. Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health

44

90. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of

obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin

Endocrinol Metab 1998;83:847-50.

91. Elsayed EF, Tighiouart H, Weiner DE, et al. Waist-to-hip ratio and body mass index

as risk factors for cardiovascular events in CKD. Am J Kidney Dis 2008;52:49-57.

92. Seidell JC, Bouchard C. Visceral fat in relation to health: is it a major culprit or simply

an innocent bystander? Int J Obes Relat Metab Disord 1997;21:626-31.

93. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM. Relationships of

generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995;96:88-98.

94. Alexander HG, Dugdale AE. Fascial planes within subcutaneous fat in humans. Eur J

Clin Nutr 1992;46:903-6.

95. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of

non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol

1997;145:614-9.

96. Rimm EB, Stampfer MJ, Giovannucci E, et al. Body size and fat distribution as

predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol

1995;141:1117-27.

97. Folsom AR, Kaye SA, Sellers TA, et al. Body fat distribution and 5-year risk of death

in older women. JAMA 1993;269:483-7.

98. Odamaki M, Furuya R, Ohkawa S, et al. Altered abdominal fat distribution and its

association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial

Transplant 1999;14:2427-32.

99. Yamauchi T, Kuno T, Takada H, Nagura Y, Kanmatsuse K, Takahashi S. The impact

of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis

45

100. Lu Q, Cheng LT, Wang T, et al. Visceral fat, arterial stiffness, and endothelial

function in peritoneal dialysis patients. J Ren Nutr 2008;18:495-502.

101. Gohda T, Gotoh H, Tanimoto M, et al. Relationship between abdominal fat

accumulation and insulin resistance in hemodialysis patients. Hypertens Res 2008;31:83-8.

102. Gotoh H, Gohda T, Tanimoto M, Gotoh Y, Horikoshi S, Tomino Y. Contribution of

subcutaneous fat accumulation to insulin resistance and atherosclerosis in haemodialysis

patients. Nephrol Dial Transplant 2009;24:3474-80.

103. Ohlson LO, Larsson B, Svardsudd K, et al. The influence of body fat distribution on

the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of

men born in 1913. Diabetes 1985;34:1055-8.

104. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of

adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants

in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed)

1984;289:1257-61.

105. Wang Z, Hoy WE. Waist circumference, body mass index, hip circumference and

waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr

2004;58:888-93.

106. Shen W, Punyanitya M, Chen J, et al. Waist circumference correlates with metabolic

syndrome indicators better than percentage fat. Obesity (Silver Spring) 2006;14:727-36.

107. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk

factors predict coronary heart disease in chronic kidney disease: results from the

atherosclerosis risk in communities study. J Am Soc Nephrol 2005;16:529-38.

108. Postorino M, Marino C, Tripepi G, Zoccali C. Abdominal obesity and all-cause and

46

109. Cancello R, Tordjman J, Poitou C, et al. Increased infiltration of macrophages in

omental adipose tissue is associated with marked hepatic lesions in morbid human obesity.

Diabetes 2006;55:1554-61.

110. Apovian CM, Bigornia S, Mott M, et al. Adipose macrophage infiltration is associated

with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler

Thromb Vasc Biol 2008;28:1654-9.

111. Harman-Boehm I, Bluher M, Redel H, et al. Macrophage infiltration into omental

versus subcutaneous fat across different populations: effect of regional adiposity and the

comorbidities of obesity. J Clin Endocrinol Metab 2007;92:2240-7.

112. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose

tissue. J Clin Invest 2003;112:1785-8.

113. Wiecek A, Adamczak M, Chudek J. Adiponectin--an adipokine with unique metabolic

properties. Nephrol Dial Transplant 2007;22:981-8.

114. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate

antidiabetic metabolic effects. Nature 2003;423:762-9.

115. Hattori Y, Suzuki M, Hattori S, Kasai K. Globular adiponectin upregulates nitric oxide

production in vascular endothelial cells. Diabetologia 2003;46:1543-9.

116. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion

molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999;100:2473-6.

117. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2

diabetes mellitus. Lancet 2003;361:226-8.

118. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein,

47

119. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2

diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol

Metab 2001;86:1930-5.

120. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma

adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol

2002;147:173-80.

121. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat

distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age

and sex. Diabetologia 2003;46:459-69.

122. Cavusoglu E, Ruwende C, Chopra V, et al. Adiponectin is an independent predictor of

all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with

chest pain. Eur Heart J 2006;27:2300-9.

123. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely

associated with overall and central fat distribution but are not directly regulated by acute

fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin

Endocrinol Metab 2003;88:4823-31.

124. Choi KM, Lee J, Lee KW, et al. Serum adiponectin concentrations predict the

developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin

Endocrinol (Oxf) 2004;61:75-80.

125. Fernandez-Real JM, Lopez-Bermejo A, Casamitjana R, Ricart W. Novel interactions

of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol

Metab 2003;88:2714-8.

126. Wang B, Trayhurn P. Acute and prolonged effects of TNF-alpha on the expression and

secretion of inflammation-related adipokines by human adipocytes differentiated in culture.

48

127. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and

macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis

factor alpha. Arterioscler Thromb Vasc Biol 2005;25:2062-8.

128. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr.

Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest

2003;112:1796-808.

129. Fain JN, Bahouth SW, Madan AK. TNFalpha release by the nonfat cells of human

adipose tissue. Int J Obes Relat Metab Disord 2004;28:616-22.

130. Halleux CM, Takahashi M, Delporte ML, et al. Secretion of adiponectin and

regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res

Commun 2001;288:1102-7.

131. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel,

adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol

2000;20:1595-9.

132. Valsamakis G, McTernan PG, Chetty R, et al. Modest weight loss and reduction in

waist circumference after medical treatment are associated with favorable changes in serum

adipocytokines. Metabolism 2004;53:430-4.

133. Kim DM, Yoon SJ, Ahn CW, et al. Sibutramine improves fat distribution and insulin

resistance, and increases serum adiponectin levels in Korean obese nondiabetic

premenopausal women. Diabetes Res Clin Pract 2004;66 Suppl 1:S139-44.

134. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an

adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab

49

135. Holdstock C, Engstrom BE, Ohrvall M, Lind L, Sundbom M, Karlsson FA. Ghrelin

and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J

Clin Endocrinol Metab 2003;88:3177-83.

136. Goldstein BJ, Scalia R. Adiponectin: A novel adipokine linking adipocytes and

vascular function. J Clin Endocrinol Metab 2004;89:2563-8.

137. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol

2005;115:911-9; quiz 20.

138. Funahashi T, Matsuzawa Y, Kihara S. Adiponectin as a potential key player in

metabolic syndrome insights into atherosclerosis, diabetes, and cancer. Int Congress Series

2004;1262:368 - 71.

139. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and

cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol

2002;13:134-41.

140. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in

peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal

renal function. Am J Kidney Dis 2004;43:1047-55.

141. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin

concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005;62:114-8.

142. Mallamaci F, Zoccali C, Cuzzola F, et al. Adiponectin in essential hypertension. J

Nephrol 2002;15:507-11.

143. Adamczak M, Szotowska M, Chudek J, Karkoszka H, Cierpka L, Wiecek A. Plasma

adiponectin concentration in patients after successful kidney transplantation--a single-center,

50

144. Nanayakkara PW, Le Poole CY, Fouque D, et al. Plasma adiponectin concentration

has an inverse and a non linear association with estimated glomerular filtration rate in patients

with K/DOQI 3 - 5 chronic kidney disease. Clin Nephrol 2009;72:21-30.

145. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin

in chronic kidney disease is related more to metabolic disturbances than to decline in renal

function. Nephrol Dial Transplant 2005;20:129-34.

146. Adamczak M, Chudek J, Wiecek A. Adiponectin in patients with chronic kidney

disease. Semin Dial 2009;22:391-5.

147. Marchlewska A, Stenvinkel P, Lindholm B, et al. Reduced gene expression of

adiponectin in fat tissue from patients with end-stage renal disease. Kidney Int 2004;66:46-50.

148. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant

stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-38.

149. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and

its impact on metabolic syndrome. J Clin Invest 2004;114:1752-61.

150. Fasshauer M, Kralisch S, Klier M, et al. Adiponectin gene expression and secretion is

inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun

2003;301:1045-50.

151. Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour

necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary

human preadipocytes. Horm Metab Res 2000;32:548-54.

152. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein

with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671-4.

153. Engeli S, Feldpausch M, Gorzelniak K, et al. Association between adiponectin and